top of page
Fresh Blood Bag
Recruitment is ongoing

On going studies at NHS Belmont Health Centre

BaxDuo Arctic Study

A Phase III, Randomised, Double-Blind, Active-controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure.

Sponsor

Astrazeneca-Emblem.png
Open to recruitment

BaxHTN Study

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension.

Sponsor

Astrazeneca-Emblem.png
OBGYN Visit
Non- Commercial Study

DURATION UTI

Impact of duration of antibiotic treatment on symptoms, recovery and antibiotic resistance in adult women with urinary tract infections (UTIs): a randomised controlled trial.

Sponsor

University_of_Oxford-Logo_edited.jpg

This research aims to find the shortest antibiotic treatment duration needed to effectively treat urinary tract infections (UTIs) in women. We will also examine the impact of each antibiotic and treatment duration on antibiotic resistance in bacteria found in the patient’s urine.

Non- Commercial Study

OPTIMISE2

Optimising Treatment for Mild Hypertension in Older People at Risk of Adverse Events.

The OPTIMISE 2 trial will establish whether deprescribing common drugs that lower blood pressure is safe or effective in older people in the longer term (a year or more). 

Sponsor

University_of_Oxford-Logo_edited.jpg

Join us here for daily updates.

Asset 1.png

INQUIRIES
Agana Nanayakkara 

Senior Clinical Research Coordinator

INQUIRIES

Jayabalan Nimmiya Aravinth

Clinical Research Coordinator

Email: agana@clinicaloneltd.com
Phone: +44 7404 121772

Email: nimmiya@clinicaloneltd.com
Phone: +44 7423 253765

© 2023 by ClinicalOne Ltd

24, Orville Road, Battersea, London SW11 3LR, United Kingdom

bottom of page